Home
News
Create
Screeners
Insights
Bacil Pharma
49.
58
+2.35
(+4.98%)
Market Cap
₹71.17 Cr
PE Ratio
92.61
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+4.98%
1M
+18.44%
6M
+49.11%
1Y
+35.50%
5Y
+1,080.48%
View Company Insights
Latest news about Bacil Pharma
Bacil Pharma Responds to BSE on Stock Price Movement Clarification
Feb 24, 2026
Bacil Pharma Limited responded to BSE's February 24, 2026 inquiry about stock price movements, confirming no unpublished price sensitive information exists. The company attributed recent fluctuations to market-driven factors and reaffirmed compliance with SEBI regulations and commitment to transparency.
Norbexi Industries Limited Completely Divests 14.46% Stake in Bacil Pharma Limited
Feb 23, 2026
Bacil Pharma Reports Strong Q3FY26 Turnaround with ₹3.92 Lakh Profit
Feb 13, 2026
Khem-Sum Apparels Overseas Ltd. Disposes Complete Stake in Bacil Pharma Limited
Dec 30, 2025
Bacil Pharma Promoter Suman P. Shah Sells Shares
Dec 29, 2025
More news about Bacil Pharma
19
Dec 25
Bacil Pharma Limited Appoints New Company Secretary Following Recent Resignation
Bacil Pharma Limited announced the proposed appointment of Mr. Dikshant Singh Panwar as Company Secretary, replacing Bhavana Phoolchand Tak who resigned effective December 1, 2025. The new appointee holds membership number ACS42741 and has extensive compliance experience. The appointment requires board confirmation and follows SEBI regulatory requirements.
Bacil Pharma
49.
58
+
2.
35
(+
4.
98
%)
1 Year Returns:
+35.50%
Industry Peers
Sun Pharmaceutical
1,796.10
(-
0.
31
%)
Divis Laboratories
6,067.50
(-
0.
06
%)
Torrent Pharmaceuticals
4,359.70
(-
0.
69
%)
Dr Reddys Laboratories
1,287.80
(-
0.
35
%)
Cipla
1,319.20
(+
0.
34
%)
Lupin
2,305.60
(-
0.
40
%)
Zydus Life Science
900.10
(-
0.
64
%)
Mankind Pharma
2,123.00
(-
0.
74
%)
Aurobindo Pharma
1,301.20
(+
0.
36
%)
Alkem Laboratories
5,326.50
(-
0.
54
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO